GO
Loading...

Baxter International Inc

More

  • Final Glance: Pharmaceuticals companies Friday, 12 Sep 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 39 or. 5 percent, to $74.70. Bristol-Myers Squibb Co. fell$. 42 or. 8 percent, to $50.26. Hospira fell$. 36 or. 7 percent, to $52.63.

  • Midday Glance: Medical Devices companies Friday, 12 Sep 2014 | 1:19 PM ET

    Allergan rose$. 56 or. 3 percent, to $168.89. Baxter International Inc. fell$. 43 or. 6 percent, to $74.66. Boston Scientific Corp. fell$. 03 or. 2 percent, to $12.51.

  • Midday Glance: Pharmaceuticals companies Friday, 12 Sep 2014 | 1:19 PM ET

    Baxter International Inc. fell$. 43 or. 6 percent, to $74.66. Bristol-Myers Squibb Co. fell$. 40 or. 8 percent, to $50.28. Hospira fell$. 35 or. 7 percent, to $52.64.

  • Early Glance: Pharmaceuticals companies Friday, 12 Sep 2014 | 11:13 AM ET

    Baxter International Inc. fell$. 26 or. 3 percent, to $74.83. Bristol-Myers Squibb Co. fell$. 12 or. 2 percent, to $50.56. Hospira fell$. 07 or. 1 percent, to $52.92.

  • Early Glance: Medical Devices companies Friday, 12 Sep 2014 | 11:13 AM ET

    Allergan fell$. 22 or. 1 percent, to $168.12. Baxter International Inc. fell$. 26 or. 3 percent, to $74.83. St. Jude Medical Inc. fell$. 38 or. 6 percent, to $64.45.

  • Final Glance: Medical Devices companies Thursday, 11 Sep 2014 | 6:02 PM ET

    Allergan rose $1.60 or 1.0 percent, to $168.33. Baxter International Inc. fell$. 19 or. 3 percent, to $75.09. Boston Scientific Corp. rose$. 03 or. 2 percent, to $12.54.

  • Midday Glance: Pharmaceuticals companies Thursday, 11 Sep 2014 | 2:09 PM ET

    Baxter International Inc. fell$. 19 or. 2 percent, to $75.10. Bristol-Myers Squibb Co. fell$. 42 or. 8 percent, to $50.66. Hospira fell$. 16 or. 3 percent, to $53.00.

  • Midday Glance: Medical Devices companies Thursday, 11 Sep 2014 | 2:09 PM ET

    Allergan rose$. 64 or. 4 percent, to $167.37. Baxter International Inc. fell$. 19 or. 2 percent, to $75.10. Boston Scientific Corp. fell$. 04 or. 3 percent, to $12.48.

  • Early Glance: Medical Devices companies Thursday, 11 Sep 2014 | 10:29 AM ET

    Allergan rose$. 26 or. 2 percent, to $166.99. Baxter International Inc. fell$. 28 or. 4 percent, to $75.00. Boston Scientific Corp. fell$. 01 or. 1 percent, to $12.50.

  • Early Glance: Pharmaceuticals companies Thursday, 11 Sep 2014 | 10:29 AM ET

    Baxter International Inc. fell$. 28 or. 4 percent, to $75.00. Bristol-Myers Squibb Co. fell$. 26 or. 5 percent, to $50.82. Hospira fell$. 03 or. 1 percent, to $53.12.

  • Final Glance: Pharmaceuticals companies Wednesday, 10 Sep 2014 | 6:16 PM ET

    Baxter International Inc. rose $1.01 or 1.4 percent, to $75.28. Bristol-Myers Squibb Co. rose$. 60 or 1.2 percent, to $51.08. Hospira rose$. 14 or. 3 percent, to $53.15.

  • Final Glance: Medical Devices companies Wednesday, 10 Sep 2014 | 6:16 PM ET

    Allergan rose$. 61 or. 4 percent, to $166.73. Baxter International Inc. rose $1.01 or 1.4 percent, to $75.28. Boston Scientific Corp. rose$. 13 or 1.1 percent, to $12.51.

  • Midday Glance: Medical Devices companies Wednesday, 10 Sep 2014 | 1:21 PM ET

    Allergan rose $1.18 or. 7 percent, to $167.30. Baxter International Inc. rose$. 84 or 1.1 percent, to $75.11. Boston Scientific Corp. rose$. 15 or 1.2 percent, to $12.53.

  • Midday Glance: Pharmaceuticals companies Wednesday, 10 Sep 2014 | 1:21 PM ET

    Baxter International Inc. rose$. 84 or 1.1 percent, to $75.11. Bristol-Myers Squibb Co. rose$. 70 or 1.4 percent, to $51.18. Johnson& Johnson rose $1.10 or 1.1 percent, to $104.90.

  • Early Glance: Pharmaceuticals companies Wednesday, 10 Sep 2014 | 10:32 AM ET

    Baxter International Inc. rose$. 44 or. 6 percent, to $74.71. Bristol-Myers Squibb Co. rose$. 27 or. 5 percent, to $50.75. Johnson& Johnson rose$. 41 or. 4 percent, to $104.21.

  • Early Glance: Medical Devices companies Wednesday, 10 Sep 2014 | 10:32 AM ET

    Allergan fell$. 48 or. 3 percent, to $165.65. Baxter International Inc. rose$. 44 or. 6 percent, to $74.71. Boston Scientific Corp. rose$. 06 or. 5 percent, to $12.44.

  • Aug 21- Baxter International Inc said a more potent version of its flagship blood disorder drug Advate met the main goal in a late-stage study.

  • NEW YORK/ WASHINGTON, Aug 9- All three U.S. facilities established to quickly make vaccines and therapeutics in the event of a major public health threat say they are standing by to support any U.S. government effort to scale up a treatment for Ebola.

  • The FDA, which had raised concerns that some patients developed antibodies to one component of the treatment, is not obliged to follow the advice of its advisory panels but typically does so. The FDA had asked whether certain subgroups of patients, such as pregnant women, should be excluded.

  • UPDATE 2-Gambro acquisition boosts Baxter's sales Thursday, 17 Jul 2014 | 1:30 PM ET

    July 17- Medical device and drug maker Baxter International Inc reported higher-than-expected quarterly adjusted earnings, driven primarily by a surge in sales of the dialysis products it gained from its acquisition of Gambro AB last year.